Olanzapine attenuates the reinforcing effects of cocaine

European Journal of Pharmacology

Volumn 340, Issue 1, 1997, Pages 17-26

  Meil, William M ^a   Schechter, Martin D ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Cocaine; Conditioned place preference; Locomotor activity; Olanzapine; Rat; Self administration

Indexed keywords

COCAINE; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD PREFERENCES; MALE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

EID: 0031553384     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01351-4     Document Type: Article

References (61)

1. Arnt J. Differential effects of classical and newer antipsychotics on hypermotility induced by two dose levels of D-amphetamine. Eur. J. Pharmacol. 283:1995;55-62.
2. Aulisi E.F., Hoebel B.G. Rewarding effects of amphetamine and cocaine in the nucleus accumbens are blocked by alpha-flupenthixol. Soc. Neurosci. Abstr. 9:1983;121.
3. Batholoni G. Preferential effect of noncataleptic neuroleptics on mesolimbic dopaminergic function. Adv. Biochem. Pharmacol. 16:1977;607-614.
4. Bevenga M.J., Leander J.D. Olanzapine, an a typical antipsychotic, increases rates of punished responding in pigeons. Pharmacology. 119:1995;133-138.
5. Britton D.R., Curzon P., Mackenzie R.G., Kebabian J.W., Williams J.E.G., Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:1991;911-915.
6. Bruhwyler J., Chleide E., Mercier M. Clozapine: An atypical neuroleptic. Neurosci. Biobehav. Rev. 14:1990;357-363.
7. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., Seeman P., Wong D.T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropharmacology. 14:1996;87-96.
8. Carr, G.D., Fibiger, H.C., Phillips, A.C., 1989. Conditioned place preference as a measure of drug reward. In: Liebman, J.M., Cooper, S.J. (Eds.), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264-319.
9. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218.
10. Caine, S.B., Lintz, R., Koob, G.F., 1993. Intravenous drug self-administration techniques in animals. In: Sahgal, A. (Ed.), Behavioral Neuroscience: A Practical Approach, vol. 1. IRL Press, Oxford, pp. 117-143.
11. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine place preference. Brain Res. 673:1995;242-250.
12. Corrigall W.A., Coen K.M. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol. Biochem. Behav. 39:1991;799-802.
13. Ebadi M., Srinivasan S.K. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders. Pharmacol. Rev. 47:1995;575-604.
14. Emmett-Oglesby M.W., Spencer D.G. Jr., Arnouly D.E. A TRS-80-based system for the control of behavioral experiments. Pharmacol. Biochem. Behav. 17:1982;583-587.
15. Gawin F.H. Neuroleptic reductions of cocaine-induced paranoia but not euphoria? Psychopharmacology. 90:1986;142-143.
16. Gawin F.H., Allen D., Humblestone B. Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate: A preliminary report. Arch. Gen. Psychiatry. 46:1989;322-325.
17. Geter-Douglass B., Riley A.L. Dopamine D1/D2 antagonist combinations as antagonists of the discriminative effects of cocaine. Pharmacol. Biochem. Behav. 54:1996;439-451.
18. Gleason S.D., Shannon H.E. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology. 129:1997;79-84.
19. Glowa J.R., Wojnicki F.H.E. Effects of drugs on food- and cocaine-maintained responding III: Dopaminergic antagonists. Psychopharmacology. 128:1996;351-358.
20. Hand T.H., Hu X.T., Wang R.Y. Differential effects of acute clozapine and haloperidol on activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res. 415:1987;257-263.
21. Hemby S.E., Smith J.E., Dworkin S.I. The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J. Pharmacol. Exp. Ther. 277:1996;1247-1258.
22. Hubner C.B., Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology. 105:1991;151-156.
23. Kleven M.S., Woolverton W.L. Effects of continuous infusion of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav. Pharmacol. 1:1990;365-373.
24. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
25. Kosten T.A., DeCaprio J.L., Nestler E.J. Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure. Psychopharmacology. 128:1996;304-312.
26. Kosten T.A., Nestler E.J. Clozapine attenuates cocaine conditioned place preference. Life Sci. 55:1994;PL9-PL14.
27. Lacosta S., Roberts D.C.S. MDL 7222, ketanserin, and methysergide pretreatment fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 44:1993;161-165.
28. Loh E.A., Roberts D.C.S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increases following depletion of forebrain serotonin. Psychopharmacology. 101:1990;262-266.
29. Loh E.A., Fitch T., Vickers G., Roberts D.C.S. Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 42:1992;559-562.
30. Meil, W.M., Boja, J.W., Schechter, M.D., 1997. Olanzapine attenuates the discriminative stimulus and reinforcing effects of cocaine. Coll. Prob. Drug Dependence Abstr., 105.
31. Meil W., See R.E. Single preexposure to fluphenazine produces persisting behavioral sensitization accompanied by tolerance to fluphenazine-induced striatal dopamine overflow in rats. Pharmacol. Biochem. Behav. 48:1994;605-612.
32. 2 pKi values. J. Pharmacol. Exp. Ther. 251:1989;238-246.
33. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:1986;33-41.
34. Moore N.A., Rees G., Sanger G., Tye N.C. Effect of olanzapine and other antipsychotic agents on responding maintained by a conflict-schedule. Behav. Pharmacol. 5:1994;196-202.
35. Moore N.A., Tye N.C., Axton M.S., Risius F.C. The behavioral pharmacology of olanzapine, a novel 'atypical' antipsychotic agent. J. Pharmacol. Exp. Ther. 262:1992;545-551.
36. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol. Biochem. Behav. 39:1991;133-136.
37. Peltier R., Schenk S. Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology. 110:1993;390-394.
38. Pettit H.O., Justice J.B. Jr. Effects of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 539:1991;94-102.
39. Pizzi W.J., Cook D.F. Conditioned taste aversion as a confound in behavioral studies that report a reduction in the reinforcing effects of drugs. Pharmacol. Biochem. Behav. 53:1996;243-247.
40. Porrino M.C., Ritz M.C., Goodman N.L., Sharpe L.G., Kuhar M.J., Goldgerg S.R. Differential effects of pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci. 45:1989;1529-1535.
41. Pruitt D.L., Bolanos C.A., McDougall S.A. Effects of dopamine D1 and D2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats. Eur. J. Pharmacol. 283:1995;125-131.
42. Rech R. Neurolepsis: Anhedonia or blunting of emotional reactivity. Behav. Brain Sci. 5:1982;72-84.
43. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
44. Roberts D.C.S., Corcoran M.E., Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:1977;615-620.
45. Roberts D.C.S., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17:1982;901-904.
46. Roberts D.C.S., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:1980;781-787.
47. Roberts D.C.S., Loh E.A., Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats: Dose-response relationship and effect of haloperidol pretreatment. Pharmacology. 97:1989;535-538.
48. Roberts D.C.S., Vickers G. Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioral screen for antipsychotic activity. Psychopharmacology. 82:1984;135-139.
49. Schechter M.D., Calcagnetti D.J. Trends in place-preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci. Biobehav. Rev. 17:1993;21-41.
50. See R.E., Ellison G. Comparison of chronic administration of haloperidol and atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur. J. Pharmacol. 181:1990;175-186.
51. Sherer M.A., Kumor K.M., Jaffe J.H. Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 27:1989;117-125.
52. Spyraki C., Fibiger H.C., Phillips A.G. Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 253:1982;195-203.
53. Van Tol H.H.M., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznick H.B., Civelli O. Cloning of a gene for the human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
54. Vanover K.E., Piercey M.F., Woolverton W.L. Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ 76 or clozapine. J. Pharmacol. Exp. Ther. 266:1993;780-789.
55. Wilson M.C., Schuster C.R. The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmocologia. 26:1972;115-126.
56. Wise R.A., Hoffman D.C. Localization of drug reward mechanisms by intracranial injections. Synapse. 10:1992;247-263.
57. Witkin J.M. The pharmacology of cocaine abuse: Preclinical development. Neurosci. Biobev. Rev. 18:1994;121-142.
58. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopamine compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:1991;706-713.
59. Woolverton W.L. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:1986;531-535.
60. Woolverton W.L., Virus R.M. The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32:1989;691-697.
61. Yokel R.A., Wise R.A. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology. 48:1976;311-318.